Bressler, Neil M.Arnold, JenniferBenchaboune, MustaphaBlumenkranz, Mark S.Fish, Gary E.Gragoudas, Evangelos S.Lewis, HilelSchmidt-Erfurth, UrsulaSlakter, Jason S.Bressler, Susan B.Manos, KellyHao, YongHayes, LaurieKoester, JohnReaves, AlStrong, H. Andrew2007-07-202007-07-202007-07-20200210.1001/archopht.120.11.1443https://infoscience.epfl.ch/handle/20.500.14299/967612427056To explore how baseline lesion composition influenced vision outcomes in patients with age-related macular degeneration (AMD) undergoing photodynamic therapy with verteporfin (Visudyne) for subfoveal choroidal neovascularization (CNV) in the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy Investigation.Photomedicine groupPhotochemotherapyVerteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration - Additional information regarding baseline lesion composition's impact on vision outcomes - TAP report No. 3text::journal::journal article::research article